investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Validating Syk as a Target for AML Therapy

Kimberly Stegmaier

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

No posts

Related projects

H Leighton Grimes

Developing Novel STAT5 Protein Inhibitors for Treatment of Leukemias

Leukaemia

Pathology Hematology and hematologic malignancies

Joseph H Antin

A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT

Leukaemia

Christopher Y Park

Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia

Leukaemia

Clark W Distelhorst

Bcl-2 Function on the Endoplasmic Reticulum

Leukaemia

Pathology Hematology and hematologic malignancies

Alan Rein

Interactions of APOBEC3 Proteins with Murine Leukemia Viruses

Leukaemia

Pathology Hematology and hematologic malignancies

David Marc Weinstock

Polysomy 21 in Acute Lymphoblastic Leukemia

Leukaemia

Marina Y Konopleva

Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia

Leukaemia

George A Calin

Protein-coding and non-coding RNA biomarkers for early detection of CLL

Leukaemia

Christopher J Ott

Chemical Modulation of Chromatin Signaling in Lymphoid Malignancies

Leukaemia